Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874327 · ClinicalTrials.gov registry record · NA
Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01874327: Completed NA study, sponsored by University of California, Los Angeles.
NCT01874327 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874327, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.
Primary Outcome
10 minute unstructured free play assessment with caregiver and child measuring change over the duration of the study.
Interventions
- BEHAVIORAL Baby JASPER
- BEHAVIORAL Standard Baby Classroom
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT01874327 record still lists
NCT01874327 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Baby JASPER is the first listed.
NCT01874327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01874327 about?
NCT01874327 is a clinical study titled "Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)". The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.
What is the current status of trial NCT01874327?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-01. Estimated completion is 2018-09.
What interventions are being tested in trial NCT01874327?
The interventions under investigation include: Baby JASPER (BEHAVIORAL), Standard Baby Classroom (BEHAVIORAL).
Who is sponsoring clinical trial NCT01874327?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01874327's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia